NYSE · Healthcare · Medical Care Facilities · USA
Guardian Pharmacy Services Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Care Facilities industry.
Guardian Pharmacy Services provides technology-enabled pharmacy solutions to long-term care facilities including assisted living facilities, behavioral health facilities, and skilled nursing facilities across multiple states. The company offers specialized services such as medication compliance packaging, robotic dispensing, caregiver training, and electronic medication administration record integration to help residents adhere to drug regimens and reduce administrative complexities.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Guardian Pharmacy Services Inc stock.
Overvalued: intrinsic value $27.19 per share, market price $41.87, margin of safety -54.0% (as of 2026-10-20).
Discounting its cash flows at 9.3% (average of 3 methods) values the shares at $27.19; the price of $41.87 is 54% above that value, and 76% of that value comes from beyond year five.
Leak Score: 56/100 on 6 of 12 signals (Weak Signal).
17 more funds hold it; the full list is part of the paid plan.
All 48 Medical Care Facilities stocks
19 more in this industry show a wider margin of safety.
GRDN is overvalued (as of the 2026-10-20 close). Discounting its cash flows at 9.3% (average of 3 methods) values the shares at $27.19; the price of $41.87 is 54% above that value, and 76% of that value comes from beyond year five.
$27.19 per share (as of the 2026-10-20 close), against a market price of $41.87. That is a margin of safety of -54.0%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
56 out of 100, which we rate "Weak Signal", on 6 of 12 value investing signals.